Mezzion Pharma Co.Ltd Cash Flow Quality Index

Latest as of June 2026: -0.62x

Mezzion Pharma Co.Ltd cash flow quality index. Mezzion Pharma Co.Ltd (140410) has a Cash Flow Quality Index of -0.62x as of June 2026. Operating cash flow of ₩-4.75 Billion is below net income of ₩7.69 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Mezzion Pharma Co.Ltd service its debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.62x
Operating CF / Net Income

Operating Cash Flow

₩-4.75 Billion
KRW

Net Income

₩7.69 Billion
KRW

Data as of

Jun 2026
Most recent filing

Cash Flow Quality Index of Mezzion Pharma Co.Ltd (2012–2015)

Cash flow quality index of Mezzion Pharma Co.Ltd from 2012 to 2015. Historical Cash Flow Quality Index for Mezzion Pharma Co.Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 140410 net asset quality score to measure how much of total assets are equity-financed.

Mezzion Pharma Co.Ltd Cash Flow Quality Index by Year (2012–2015)

Mezzion Pharma Co.Ltd cash flow quality index by year from 2012 to 2015. Year-by-year earnings quality comparison for Mezzion Pharma Co.Ltd. For the full cash flow conversion analysis, see Mezzion Pharma Co.Ltd cash conversion from operations.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2015 0.34x ₩1.77 Billion ₩5.16 Billion ▼ -73.9%
2012 1.32x ₩3.14 Billion ₩2.38 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.